ARCHIVES

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

April 15, 2011

NCAB Committee To Propose Event Marking Cancer Act

August 2, 1991

DCCR Advisory Committee Delays Planned Expansion Of Promising Community Clinical Oncology Program

July 21, 1978

Fermilab Treats 1,000th Patient

August 7, 1981

Holland On The Next 10 Years; Progress In Prevention, Diagnosis, Therapy

March 23, 1984

NCI says SELECT study is close to full enrollment.

April 23, 2004